WhenToTest.org Develops Online Tools for Effective COVID-19 Testing Duplicate 0 - CIMIT MAIN

Responsive Image
The FDA has approved the first rapid hepatitis C virus test for the U.S. market that can be used in patient care settings. The test, which was validated in part by the NIH RADx Tech program with funding from CDC, can provide results in about one hour, meaning patients with a positive test can begin treatment right away. We're honored to have been a part of the journey behind this important milestone! 

Learn more about this game changer for hepatitis C diagnosis >

Programs and Offerings

News and Events

null WhenToTest.org Develops Online Tools for Effective COVID-19 Testing Duplicate 0

WhenToTest.org Develops Online Tools for Effective COVID-19 Testing

New Resources Help Schools and Businesses Reduce the Risk of an Outbreak


BOSTON (July 20, 2021) — WhenToTest.org announced today the release of a revamped online platform to make it even easier for schools and employers to safely remain open or resume in-person operations. The website includes a decision support tool to assist leaders in determining how to implement an effective COVID-19 testing program for their institutions. Specific enhancements include: 

  • An improved interface to help guide leaders to determine what should influence their COVID-19 testing strategy, including how vaccination rates impact testing frequency 
  • Insights to help leaders compare different testing approaches, such as rapid tests, PCR tests, pooled tests, and how frequently the tests should be administered to a population 
  • Educational content for implementing a testing program 
  • A more streamlined experience for purchasing testing supplies through Project N95’s clearinghouse

The Consortia for Improving Medicine with Innovation and Technology (CIMIT) and the Massachusetts Institute of Technology Institute for Data Systems and Society (MIT IDSS) developed WhenToTest.org with support from the National Institutes of Health’s RADx Tech program. 

Nancy Gagliano, M.D., Implementation Lead, RADx Tech said, “When NIBIB supported the development of WhenToTest.org last fall, we wanted to provide organizations with clear guidance on how to mitigate the spread of COVID-19 in their organizations. Even with the rollout of vaccines, testing is still a critical tool to ensure COVID-19 stays in check, and this new website will give leaders comprehensive guidance and support to implement or improve on their testing programs.” 

“In just over one year, RADx has helped dramatically expand COVID-19 testing choices and capacity,” said Bruce Tromberg, Ph.D., director of the National Institute of Biomedical Imaging and Bioengineering, part of NIH. “WhenToTest.org can help organizations evaluate a wide range of options and build the right program specifically for their needs and budget.” 

###

About WhenToTest.org: WhenToTest.org is an online platform that supports organizations in establishing effective COVID-19 mitigation strategies. The platform contains an evidence-based modeling tool to help organizations determine their testing needs and a comprehensive set of educational resources. WhenToTest.org is a joint project between the Consortia for Improving Medicine with Innovation and Technology (CIMIT) and the Massachusetts Institute of Technology Institute for Data Systems and Society (MIT IDSS) with support from the National Institute of Health’s RADx Tech program.

Contact: Tracy McMahon

Connect with Us

Our Lasting Impact

As an early pioneer in managing translational research, CIMIT has directly supported over 1,200 innovator teams and reviewed or consulted on over 5,000 ideas since our founding in 1998.

We work collaboratively with healthtech innovators, entrepreneurs, and institutions to ultimately make a positive impact on patient care across the globe. We streamline pathways to progress through our efficient processes, established systems, and unparalleled market expertise.